News
In recent months, Trump has rolled back some of his steepest tariffs, meaning delays could be possible in the case of the Aug. 1 deadline. The Trump administration appears to have stood largely behind ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.
These exports are now exposed to sharply higher U.S. tariffs, threatening the profitability of Indian producers and exporters,”says founder of Global Trade Research Initiative (GTRI) Ajay Srivastava.
GE HealthCare Technologies' market position, rising earnings, and improving financials make it an attractive investment opportunity. Read more on GEHC stock.
Trump’s budget proposal, from May, seeks to slash the Department of Health and Human Services’ budget by $31.3 billion ...
ADI shares flashed a Golden Cross pattern on July 1, when the 50-day moving average crossed above the 200-day, a classic ...
The two sides have yet to yield a decisive breakthrough despite an earlier round of negotiations in Washington last week.
President Trump is right to crack down on unfair trade practices and bring manufacturing back to American soil. Here in ...
President Donald Trump has threatened tariffs on drugs coming from overseas, but it might take more than that to reroute the ...
Tariffs pose rising inflation and rate cut risks for H2 2025 as CPI data hints at early price pressures in key goods. See why ...
Amneal Pharmaceuticals LLC: Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
Results Reflect Continued Financial Strength and Deleveraging - BRIDGEWATER, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today annou ...
Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results